Bonapace Charles R, Friedrich Lawrence V, Bosso John A, White Roger L
Anti-Infective Research Laboratory, College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Antimicrob Agents Chemother. 2002 Nov;46(11):3574-9. doi: 10.1128/AAC.46.11.3574-3579.2002.
Animal infection models have historically been used to study pharmacodynamic relationships. Similar results could theoretically be produced by using an in vitro pharmacodynamic model as an alternative to animal models. We compared the antibiotic effects of ticarcillin administered in various doses and dosing regimens against Pseudomonas aeruginosa ATCC 27853 under conditions analogous to those previously employed in a neutropenic-mouse thigh infection model (B. Vogelman et al., J. Infect. Dis. 158:831-847, 1988). Ticarcillin dosages of either 96, 192, or 384 mg/day were administered at 1-, 2-, 3-, 4-, 8-, 12-, or 24-h intervals into a two-compartment model in order to duplicate the concentration-time profiles of the animal model. Colony counts were enumerated at 0 and 24 h. Linear regression and sigmoidal maximum-effect (Emax) model fitting were used to assess the relationship between the percentage of time that the concentration remained above the MIC (%T>MIC) or above four times the MIC (%T>4xMIC) and the change in the log(10) CFU per milliliter (Deltalog(10) CFU/ml) in the central and peripheral compartments. Statistical analysis of the Deltalog(10) CFU/ml values was performed for matched regimens of the in vitro and animal models based on the %T>MICs. The slopes of the regression equations of %T>MICs relative to Deltalog(10) CFU/ml values were similar for the in vitro and animal models, but the y intercept was greater with the in vitro model. The Deltalog(10) CFU/ml values of the 0- to 24-h colony counts at equivalent %T>MICs in the two models were not statistically different (P = 0.087). Overall, the peripheral compartment of the in vitro model was a better predictor of effect than the central compartment. This study, which compares pharmacodynamic principles between an in vitro and an animal model, demonstrated similar relationships between %T>MICs and effects.
动物感染模型一直以来都被用于研究药效学关系。从理论上讲,使用体外药效学模型作为动物模型的替代方法也能得出类似的结果。我们在类似于先前用于中性粒细胞减少小鼠大腿感染模型(B. 沃格尔曼等人,《传染病杂志》158:831 - 847, 1988)的条件下,比较了不同剂量和给药方案的替卡西林对铜绿假单胞菌ATCC 27853的抗菌效果。将96、192或384毫克/天的替卡西林剂量按1、2、3、4、8、12或24小时的间隔给药到一个双室模型中,以复制动物模型的浓度 - 时间曲线。在0小时和24小时时进行菌落计数。使用线性回归和S形最大效应(Emax)模型拟合来评估浓度保持高于最低抑菌浓度(%T>MIC)或高于四倍最低抑菌浓度(%T>4xMIC)的时间百分比与中央和外周室中每毫升对数(10)菌落形成单位(Deltalog(10) CFU/ml)变化之间的关系。基于%T>MICs,对体外模型和动物模型的匹配给药方案进行了Deltalog(10) CFU/ml值的统计分析。体外模型和动物模型中%T>MICs相对于Deltalog(10) CFU/ml值的回归方程斜率相似,但体外模型的y轴截距更大。两个模型中在等效%T>MICs时0至24小时菌落计数的Deltalog(10) CFU/ml值没有统计学差异(P = 0.087)。总体而言,体外模型的外周室比中央室更能预测药效。这项比较体外模型和动物模型之间药效学原理的研究表明,%T>MICs与药效之间存在相似的关系。